ANNA ROBERTS: Open Payments
NPI 1659988269 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 107 payments from 11 companies in 2025. Trend: 2023 $151 · 2024 $483 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $456 |
| Paratek Pharmaceuticals, Inc. | 18 | $386 |
| ABBVIE INC. | 20 | $360 |
| ViiV Healthcare Company | 17 | $297 |
| Theratechnologies Inc. | 9 | $225 |
| Merck Sharp & Dohme LLC | 8 | $188 |
| La Jolla Pharmaceutical Company | 6 | $122 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Teleflex LLC | 1 | $38 |
| Insmed, Inc. | 2 | $38 |
Products named: NUZYRA, EGRIFTA, DOVATO, AVYCAZ, PIFELTRO, Biktarvy, CABENUVA, ZEVTERA.
Industry payments across MS — which companies pay providers there.
